Genocea Biosciences, Inc. announced the appointment of a new Chief Financial Officer, Diantha Duvall. Ms. Duvall will join the company on March 5, 2019. Ms. Duvall joins Genocea from Bioverativ, Inc., where she served as Vice President, Controller and Chief Accounting Officer since the company’s spin out from Biogen, where she had served as U.S. and then Global Commercial Controller. Prior to Biogen, Ms. Duvall held a variety of financial and accounting positions at Merck and Co. and PricewaterhouseCoopers.